Ledger.Open graph →
SEC Form D · filed October 15, 2020

Alucent Biomedical, Inc

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Salt Lake City, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Dan D. Pelak · Salt Lake City, UTDirectorDavid N. Flicek · Salt Lake City, UTDirectorMyles D. Greenberg · Salt Lake City, UTExec · DirectorJames D. Corbett · Salt Lake City, UTDirectorJulie N. Lautt · Salt Lake City, UTDirectorScott N. Mayfield · Salt Lake City, UTExecRyan D. Hansen · Salt Lake City, UTDirectorPat D. Costello · Salt Lake City, UTDirectorDan D. Pelak · Salt Lake City, UTDirectorDavid N. Flicek · Salt Lake City, UTDirectorMyles D. Greenberg · Stamford, CTExec · DirectorJames D. Corbett · Salt Lake City, UTDirectorScott N. Mayfield · Salt Lake City, UTExecRyan D. Hansen · Salt Lake City, UTDirectorPat D. Costello · Salt Lake City, UTDirectorJulie N. Lautt · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗